CGEM
Cullinan Therapeutics, Inc.
Cullinan Therapeutics, Inc. (CGEM) has 5 SEC Form 4 filings (9 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 7, 2026.
The most active filer is Chief Scientific Officer Michaelson Jennifer with 3 filings. Insiders have net sold $385K over the trailing 6 months.
- Industry:Medical - Pharmaceuticals
- CEO:Nadim Ahmed
- Employees:109
- HQ:Cambridge, MA, US
- IPO:2021-01-08
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$385K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$1.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Scientific Officer | Sale | 8,000 | $143K | Jul 7 | SEC ↗ | |
| Chief Scientific Officer | Sale | 8,000 | $117K | May 6 | SEC ↗ | |
Michaelson JenniferFirst filing | Chief Scientific Officer | Sale | 8,000 | $125K | Mar 9 | SEC ↗ |
Related companies
Cullinan Therapeutics, Inc. is in the Healthcare sector.